Skip to main content
. 2003 Jul;41(7):2827–2834. doi: 10.1128/JCM.41.7.2827-2834.2003

FIG. 1.

FIG. 1.

(A) End point titration of HPV16 VLP conformation-specific H16.V5 MAb. (B) End point titration of an HPV16-seropositive sample (SRS-16). IgG concentrations shown on the curve were extrapolated from H16.V5 MAb reaction with the VLPs shown in panel A.